Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Santus

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Pathologie-Biologie|September 1, 1979
[Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)]J P Santus, E Henocq, B Bizzini, et al.
Respiratory Medicine|July 16, 2002
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPDM Cazzola, P Santus, F Castagna, et al.
International Journal of Clinical Pharmacology Research|August 3, 2005
Effect of inhaled combination therapy on asthma managementP Santus, F Di Marco, R Carlucci, et al.
Respiratory Medicine|March 22, 2002
Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled studyS Centanni, P Santus, F Casanova, et al.
Panminerva Medica|April 25, 2012
Biomarkers in obstructive respiratory diseases: an updateF Braido, D Bagnasco, N Scichilone, et al.
Pulmonary Pharmacology & Therapeutics|February 13, 2001
Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPDM Cazzola, S Centanni, C Regorda, et al.
Pulmonary Pharmacology & Therapeutics|December 3, 2014
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICSM Latorre, F Novelli, B Vagaggini, et al.
The European Respiratory Journal|February 7, 2003
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPDF Di Marco, J Milic-Emili, B Boveri, et al.
Respiratory Medicine|May 9, 2003
Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
The European Respiratory Journal|February 26, 2004
Detection of expiratory flow limitation in COPD using the forced oscillation techniqueR L Dellacà, P Santus, A Aliverti, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Pathologie-Biologie|September 1, 1979
[Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)]J P Santus, E Henocq, B Bizzini, et al.
Respiratory Medicine|July 16, 2002
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPDM Cazzola, P Santus, F Castagna, et al.
International Journal of Clinical Pharmacology Research|August 3, 2005
Effect of inhaled combination therapy on asthma managementP Santus, F Di Marco, R Carlucci, et al.
Respiratory Medicine|March 22, 2002
Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled studyS Centanni, P Santus, F Casanova, et al.
Panminerva Medica|April 25, 2012
Biomarkers in obstructive respiratory diseases: an updateF Braido, D Bagnasco, N Scichilone, et al.
Pulmonary Pharmacology & Therapeutics|February 13, 2001
Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPDM Cazzola, S Centanni, C Regorda, et al.
Pulmonary Pharmacology & Therapeutics|December 3, 2014
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICSM Latorre, F Novelli, B Vagaggini, et al.
The European Respiratory Journal|February 7, 2003
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPDF Di Marco, J Milic-Emili, B Boveri, et al.
Respiratory Medicine|May 9, 2003
Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPDM Cazzola, P Santus, F Di Marco, et al.
The European Respiratory Journal|February 26, 2004
Detection of expiratory flow limitation in COPD using the forced oscillation techniqueR L Dellacà, P Santus, A Aliverti, et al.
Pageof 6